ÂÜÀòÂÒÂ×

Meiyao Wang is an accomplished professional in the field of bioanalysis, currently serving as the Director of Regulated Bioanalysis at Bristol Myers Squibb. With a robust background, Meiyao previously held the position of Director and Associate Director of Bioanalytical Development at Karuna Therapeutics. Meiyao's experience also includes roles as Associate Principal Scientist and Senior Scientist at Merck, as well as serving as a Senior Service Fellow at the Centers for Disease Control and Prevention. Meiyao began a career in scientific research as Scientist II at MedImmune, AstraZeneca. Meiyao earned a Doctor of Philosophy (Ph.D.) in Analytical Chemistry from the University of Georgia Department of Chemistry.